NASDAQ:GYRE | EBITDA | GYRE THERAPEUTICS, INC.

Complete source-backed ebitda history.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$8.68M
2025-12-31$774,000.00
2025-03-31$2.81M
2024-12-31$1.13M
2024-03-31$8.49M
2023-12-31-$91.33M
2023-03-31$6.94M
2022-12-31-$21.59M
2022-03-31-$14.59M
2021-12-31-$20.2M
2021-03-31-$22.39M
2020-12-31-$18.8M
2020-03-31-$5.04M
2019-12-31-$13.95M
2019-03-31-$15.67M
2018-12-31-$11.64M
2018-03-31-$6.65M
2017-12-31-$5.79M
2017-03-31-$4.12M
2016-12-31-$5.16M
2016-03-31-$4.47M
2015-12-31-$4.58M
2015-03-31-$2.92M
2014-12-31-$1.72M
2014-03-31-$11.69M
2013-12-31$24.24M
2013-03-31-$8.06M
2012-12-31-$15.86M
2012-03-31$2.62M
2011-12-31-$9.52M
2011-03-31$12.9M
2010-12-31-$819,000.00

Annual EBITDA

DateEBITDA
2025-12-31$13.97M
2024-12-31$17.71M
2023-12-31-$66.16M
2022-12-31$10.29M
2021-12-31-$87.6M
2020-12-31-$57.23M
2019-12-31-$57.13M
2018-12-31-$33.67M
2017-12-31-$21.65M
2016-12-31-$20.03M
2015-12-31-$13.33M
2014-12-31-$6.83M
2013-12-31-$9.15M
2012-12-31-$5.93M
2011-12-31-$7.27M
2010-12-31$15.11M
2009-12-31-$38.49M